nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP1—neck—thymus cancer	0.0237	0.0827	CbGeAlD
Alitretinoin—Clotting—Octreotide—thymus cancer	0.0202	0.0283	CcSEcCtD
Alitretinoin—Ischaemia—Octreotide—thymus cancer	0.0198	0.0277	CcSEcCtD
Alitretinoin—RXRG—neck—thymus cancer	0.0187	0.0653	CbGeAlD
Alitretinoin—CRABP1—hematopoietic system—thymus cancer	0.0176	0.0615	CbGeAlD
Alitretinoin—VIIth nerve paralysis—Octreotide—thymus cancer	0.0176	0.0247	CcSEcCtD
Alitretinoin—Pancreatitis acute—Octreotide—thymus cancer	0.0156	0.0219	CcSEcCtD
Alitretinoin—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0137	0.0192	CcSEcCtD
Alitretinoin—Ear disorder—Octreotide—thymus cancer	0.0134	0.0187	CcSEcCtD
Alitretinoin—CRABP1—pituitary gland—thymus cancer	0.0131	0.0456	CbGeAlD
Alitretinoin—Local reaction—Octreotide—thymus cancer	0.013	0.0183	CcSEcCtD
Alitretinoin—Pregnancy—Octreotide—thymus cancer	0.0127	0.0178	CcSEcCtD
Alitretinoin—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.0123	0.0172	CcSEcCtD
Alitretinoin—CRABP2—pituitary gland—thymus cancer	0.0118	0.0413	CbGeAlD
Alitretinoin—RARG—hematopoietic system—thymus cancer	0.0116	0.0406	CbGeAlD
Alitretinoin—CRABP1—thyroid gland—thymus cancer	0.0113	0.0393	CbGeAlD
Alitretinoin—Nail disorder—Octreotide—thymus cancer	0.0111	0.0156	CcSEcCtD
Alitretinoin—RARA—hematopoietic system—thymus cancer	0.0109	0.0382	CbGeAlD
Alitretinoin—Redness—Octreotide—thymus cancer	0.0107	0.015	CcSEcCtD
Alitretinoin—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0106	0.0148	CcSEcCtD
Alitretinoin—Menstrual disorder—Octreotide—thymus cancer	0.0106	0.0148	CcSEcCtD
Alitretinoin—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0105	0.0147	CcSEcCtD
Alitretinoin—RXRG—pituitary gland—thymus cancer	0.0103	0.0361	CbGeAlD
Alitretinoin—CRABP2—thyroid gland—thymus cancer	0.0102	0.0356	CbGeAlD
Alitretinoin—RXRB—cardiac atrium—thymus cancer	0.00995	0.0347	CbGeAlD
Alitretinoin—Coagulopathy—Octreotide—thymus cancer	0.00927	0.013	CcSEcCtD
Alitretinoin—CRABP2—lung—thymus cancer	0.00926	0.0323	CbGeAlD
Alitretinoin—RARB—thyroid gland—thymus cancer	0.00912	0.0318	CbGeAlD
Alitretinoin—Tingling sensation—Octreotide—thymus cancer	0.00898	0.0126	CcSEcCtD
Alitretinoin—Stinging—Octreotide—thymus cancer	0.00891	0.0125	CcSEcCtD
Alitretinoin—RXRG—thyroid gland—thymus cancer	0.00891	0.0311	CbGeAlD
Alitretinoin—Numbness—Octreotide—thymus cancer	0.00871	0.0122	CcSEcCtD
Alitretinoin—Acne—Octreotide—thymus cancer	0.00858	0.012	CcSEcCtD
Alitretinoin—Neoplasm malignant—Octreotide—thymus cancer	0.00846	0.0119	CcSEcCtD
Alitretinoin—RXRB—thyroid gland—thymus cancer	0.00838	0.0292	CbGeAlD
Alitretinoin—Sensory loss—Octreotide—thymus cancer	0.00833	0.0117	CcSEcCtD
Alitretinoin—RARB—lung—thymus cancer	0.00828	0.0289	CbGeAlD
Alitretinoin—Contusion—Octreotide—thymus cancer	0.00828	0.0116	CcSEcCtD
Alitretinoin—RARA—pituitary gland—thymus cancer	0.00811	0.0283	CbGeAlD
Alitretinoin—Rectal haemorrhage—Octreotide—thymus cancer	0.00799	0.0112	CcSEcCtD
Alitretinoin—Cellulitis—Octreotide—thymus cancer	0.00794	0.0111	CcSEcCtD
Alitretinoin—Herpes simplex—Octreotide—thymus cancer	0.00783	0.011	CcSEcCtD
Alitretinoin—Drug interaction—Octreotide—thymus cancer	0.00778	0.0109	CcSEcCtD
Alitretinoin—RARA—lymphoid tissue—thymus cancer	0.0077	0.0269	CbGeAlD
Alitretinoin—RXRB—lung—thymus cancer	0.00761	0.0266	CbGeAlD
Alitretinoin—Hearing impaired—Octreotide—thymus cancer	0.00758	0.0106	CcSEcCtD
Alitretinoin—RARG—thyroid gland—thymus cancer	0.00744	0.026	CbGeAlD
Alitretinoin—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00722	0.0101	CcSEcCtD
Alitretinoin—Injection site reaction—Octreotide—thymus cancer	0.00718	0.0101	CcSEcCtD
Alitretinoin—Cystitis noninfective—Octreotide—thymus cancer	0.00705	0.00988	CcSEcCtD
Alitretinoin—Wheezing—Octreotide—thymus cancer	0.00701	0.00983	CcSEcCtD
Alitretinoin—RARA—bone marrow—thymus cancer	0.00701	0.0245	CbGeAlD
Alitretinoin—RARA—thyroid gland—thymus cancer	0.00699	0.0244	CbGeAlD
Alitretinoin—Cystitis—Octreotide—thymus cancer	0.00697	0.00977	CcSEcCtD
Alitretinoin—Candida infection—Octreotide—thymus cancer	0.00689	0.00966	CcSEcCtD
Alitretinoin—RARG—lung—thymus cancer	0.00676	0.0236	CbGeAlD
Alitretinoin—Mouth ulceration—Octreotide—thymus cancer	0.00653	0.00915	CcSEcCtD
Alitretinoin—Bladder pain—Octreotide—thymus cancer	0.00653	0.00915	CcSEcCtD
Alitretinoin—RARA—lung—thymus cancer	0.00635	0.0222	CbGeAlD
Alitretinoin—Phlebitis—Octreotide—thymus cancer	0.00608	0.00853	CcSEcCtD
Alitretinoin—Diabetes mellitus—Octreotide—thymus cancer	0.00603	0.00844	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00603	0.00844	CcSEcCtD
Alitretinoin—Deafness—Octreotide—thymus cancer	0.00586	0.00821	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Octreotide—thymus cancer	0.00578	0.0081	CcSEcCtD
Alitretinoin—Nasal congestion—Octreotide—thymus cancer	0.00575	0.00806	CcSEcCtD
Alitretinoin—RARB—lymph node—thymus cancer	0.00566	0.0198	CbGeAlD
Alitretinoin—Visual disturbance—Octreotide—thymus cancer	0.00553	0.00775	CcSEcCtD
Alitretinoin—Arthritis—Octreotide—thymus cancer	0.00539	0.00756	CcSEcCtD
Alitretinoin—Osteoarthritis—Octreotide—thymus cancer	0.00524	0.00735	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00524	0.00735	CcSEcCtD
Alitretinoin—Pain in extremity—Octreotide—thymus cancer	0.00524	0.00735	CcSEcCtD
Alitretinoin—Psychotic disorder—Octreotide—thymus cancer	0.00512	0.00717	CcSEcCtD
Alitretinoin—Irritability—Octreotide—thymus cancer	0.005	0.00701	CcSEcCtD
Alitretinoin—Dehydration—Octreotide—thymus cancer	0.00487	0.00683	CcSEcCtD
Alitretinoin—Dry skin—Octreotide—thymus cancer	0.0048	0.00673	CcSEcCtD
Alitretinoin—Nasopharyngitis—Octreotide—thymus cancer	0.00469	0.00657	CcSEcCtD
Alitretinoin—Gastritis—Octreotide—thymus cancer	0.00464	0.0065	CcSEcCtD
Alitretinoin—RARG—lymph node—thymus cancer	0.00462	0.0161	CbGeAlD
Alitretinoin—Abdominal distension—Octreotide—thymus cancer	0.00456	0.00639	CcSEcCtD
Alitretinoin—Asthma—Octreotide—thymus cancer	0.00453	0.00635	CcSEcCtD
Alitretinoin—Bronchospasm—Octreotide—thymus cancer	0.00446	0.00624	CcSEcCtD
Alitretinoin—Pancreatitis—Octreotide—thymus cancer	0.00444	0.00622	CcSEcCtD
Alitretinoin—Sweating increased—Octreotide—thymus cancer	0.00441	0.00618	CcSEcCtD
Alitretinoin—RARA—lymph node—thymus cancer	0.00434	0.0152	CbGeAlD
Alitretinoin—Abdominal discomfort—Octreotide—thymus cancer	0.00434	0.00609	CcSEcCtD
Alitretinoin—Dysuria—Octreotide—thymus cancer	0.00424	0.00594	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Octreotide—thymus cancer	0.00421	0.0059	CcSEcCtD
Alitretinoin—Pollakiuria—Octreotide—thymus cancer	0.00418	0.00586	CcSEcCtD
Alitretinoin—Weight increased—Octreotide—thymus cancer	0.00412	0.00578	CcSEcCtD
Alitretinoin—Weight decreased—Octreotide—thymus cancer	0.0041	0.00574	CcSEcCtD
Alitretinoin—Pneumonia—Octreotide—thymus cancer	0.00406	0.00569	CcSEcCtD
Alitretinoin—CYP1A2—hematopoietic system—thymus cancer	0.00405	0.0142	CbGeAlD
Alitretinoin—Drowsiness—Octreotide—thymus cancer	0.00404	0.00566	CcSEcCtD
Alitretinoin—Depression—Octreotide—thymus cancer	0.00403	0.00564	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Octreotide—thymus cancer	0.00396	0.00555	CcSEcCtD
Alitretinoin—Urinary tract infection—Octreotide—thymus cancer	0.00393	0.0055	CcSEcCtD
Alitretinoin—Conjunctivitis—Octreotide—thymus cancer	0.00393	0.0055	CcSEcCtD
Alitretinoin—Haematuria—Octreotide—thymus cancer	0.00385	0.0054	CcSEcCtD
Alitretinoin—Epistaxis—Octreotide—thymus cancer	0.00381	0.00534	CcSEcCtD
Alitretinoin—Sinusitis—Octreotide—thymus cancer	0.00379	0.00531	CcSEcCtD
Alitretinoin—Hepatitis—Octreotide—thymus cancer	0.00363	0.00508	CcSEcCtD
Alitretinoin—Hypoaesthesia—Octreotide—thymus cancer	0.00361	0.00506	CcSEcCtD
Alitretinoin—Pharyngitis—Octreotide—thymus cancer	0.0036	0.00504	CcSEcCtD
Alitretinoin—Oedema peripheral—Octreotide—thymus cancer	0.00357	0.00501	CcSEcCtD
Alitretinoin—Visual impairment—Octreotide—thymus cancer	0.00349	0.0049	CcSEcCtD
Alitretinoin—Tinnitus—Octreotide—thymus cancer	0.00338	0.00474	CcSEcCtD
Alitretinoin—Flushing—Octreotide—thymus cancer	0.00336	0.00472	CcSEcCtD
Alitretinoin—Arrhythmia—Octreotide—thymus cancer	0.00324	0.00454	CcSEcCtD
Alitretinoin—Alopecia—Octreotide—thymus cancer	0.0032	0.00449	CcSEcCtD
Alitretinoin—Mental disorder—Octreotide—thymus cancer	0.00318	0.00445	CcSEcCtD
Alitretinoin—Malnutrition—Octreotide—thymus cancer	0.00316	0.00442	CcSEcCtD
Alitretinoin—Erythema—Octreotide—thymus cancer	0.00316	0.00442	CcSEcCtD
Alitretinoin—Flatulence—Octreotide—thymus cancer	0.00311	0.00436	CcSEcCtD
Alitretinoin—Tension—Octreotide—thymus cancer	0.0031	0.00434	CcSEcCtD
Alitretinoin—Nervousness—Octreotide—thymus cancer	0.00307	0.0043	CcSEcCtD
Alitretinoin—Back pain—Octreotide—thymus cancer	0.00305	0.00428	CcSEcCtD
Alitretinoin—Vision blurred—Octreotide—thymus cancer	0.00297	0.00417	CcSEcCtD
Alitretinoin—Tremor—Octreotide—thymus cancer	0.00296	0.00414	CcSEcCtD
Alitretinoin—Ill-defined disorder—Octreotide—thymus cancer	0.00293	0.0041	CcSEcCtD
Alitretinoin—Anaemia—Octreotide—thymus cancer	0.00292	0.00409	CcSEcCtD
Alitretinoin—Agitation—Octreotide—thymus cancer	0.0029	0.00407	CcSEcCtD
Alitretinoin—Malaise—Octreotide—thymus cancer	0.00285	0.00399	CcSEcCtD
Alitretinoin—Syncope—Octreotide—thymus cancer	0.00283	0.00397	CcSEcCtD
Alitretinoin—Palpitations—Octreotide—thymus cancer	0.00279	0.00391	CcSEcCtD
Alitretinoin—Loss of consciousness—Octreotide—thymus cancer	0.00277	0.00389	CcSEcCtD
Alitretinoin—Cough—Octreotide—thymus cancer	0.00275	0.00386	CcSEcCtD
Alitretinoin—Convulsion—Octreotide—thymus cancer	0.00273	0.00383	CcSEcCtD
Alitretinoin—Hypertension—Octreotide—thymus cancer	0.00272	0.00382	CcSEcCtD
Alitretinoin—Arthralgia—Octreotide—thymus cancer	0.00269	0.00377	CcSEcCtD
Alitretinoin—Chest pain—Octreotide—thymus cancer	0.00269	0.00377	CcSEcCtD
Alitretinoin—Myalgia—Octreotide—thymus cancer	0.00269	0.00377	CcSEcCtD
Alitretinoin—Anxiety—Octreotide—thymus cancer	0.00268	0.00375	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00267	0.00374	CcSEcCtD
Alitretinoin—Discomfort—Octreotide—thymus cancer	0.00265	0.00372	CcSEcCtD
Alitretinoin—Dry mouth—Octreotide—thymus cancer	0.00263	0.00368	CcSEcCtD
Alitretinoin—CYP1A2—thyroid gland—thymus cancer	0.00259	0.00905	CbGeAlD
Alitretinoin—Anaphylactic shock—Octreotide—thymus cancer	0.00258	0.00361	CcSEcCtD
Alitretinoin—Oedema—Octreotide—thymus cancer	0.00258	0.00361	CcSEcCtD
Alitretinoin—Infection—Octreotide—thymus cancer	0.00256	0.00359	CcSEcCtD
Alitretinoin—Shock—Octreotide—thymus cancer	0.00253	0.00355	CcSEcCtD
Alitretinoin—Nervous system disorder—Octreotide—thymus cancer	0.00253	0.00354	CcSEcCtD
Alitretinoin—Thrombocytopenia—Octreotide—thymus cancer	0.00252	0.00353	CcSEcCtD
Alitretinoin—Tachycardia—Octreotide—thymus cancer	0.00251	0.00352	CcSEcCtD
Alitretinoin—Skin disorder—Octreotide—thymus cancer	0.0025	0.00351	CcSEcCtD
Alitretinoin—Hyperhidrosis—Octreotide—thymus cancer	0.00249	0.00349	CcSEcCtD
Alitretinoin—Anorexia—Octreotide—thymus cancer	0.00246	0.00344	CcSEcCtD
Alitretinoin—CYP1A2—lung—thymus cancer	0.00235	0.00822	CbGeAlD
Alitretinoin—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00235	0.00329	CcSEcCtD
Alitretinoin—Insomnia—Octreotide—thymus cancer	0.00233	0.00327	CcSEcCtD
Alitretinoin—Paraesthesia—Octreotide—thymus cancer	0.00231	0.00324	CcSEcCtD
Alitretinoin—Dyspnoea—Octreotide—thymus cancer	0.0023	0.00322	CcSEcCtD
Alitretinoin—Somnolence—Octreotide—thymus cancer	0.00229	0.00321	CcSEcCtD
Alitretinoin—Dyspepsia—Octreotide—thymus cancer	0.00227	0.00318	CcSEcCtD
Alitretinoin—Decreased appetite—Octreotide—thymus cancer	0.00224	0.00314	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Octreotide—thymus cancer	0.00222	0.00312	CcSEcCtD
Alitretinoin—Fatigue—Octreotide—thymus cancer	0.00222	0.00311	CcSEcCtD
Alitretinoin—Pain—Octreotide—thymus cancer	0.0022	0.00309	CcSEcCtD
Alitretinoin—Constipation—Octreotide—thymus cancer	0.0022	0.00309	CcSEcCtD
Alitretinoin—Feeling abnormal—Octreotide—thymus cancer	0.00212	0.00298	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Octreotide—thymus cancer	0.00211	0.00295	CcSEcCtD
Alitretinoin—ABCB1—hematopoietic system—thymus cancer	0.00208	0.00725	CbGeAlD
Alitretinoin—Urticaria—Octreotide—thymus cancer	0.00205	0.00287	CcSEcCtD
Alitretinoin—Abdominal pain—Octreotide—thymus cancer	0.00204	0.00285	CcSEcCtD
Alitretinoin—Body temperature increased—Octreotide—thymus cancer	0.00204	0.00285	CcSEcCtD
Alitretinoin—ABCB1—epithelium—thymus cancer	0.0019	0.00663	CbGeAlD
Alitretinoin—Hypersensitivity—Octreotide—thymus cancer	0.0019	0.00266	CcSEcCtD
Alitretinoin—Asthenia—Octreotide—thymus cancer	0.00185	0.00259	CcSEcCtD
Alitretinoin—Pruritus—Octreotide—thymus cancer	0.00182	0.00255	CcSEcCtD
Alitretinoin—Diarrhoea—Octreotide—thymus cancer	0.00176	0.00247	CcSEcCtD
Alitretinoin—Dizziness—Octreotide—thymus cancer	0.0017	0.00239	CcSEcCtD
Alitretinoin—Vomiting—Octreotide—thymus cancer	0.00164	0.0023	CcSEcCtD
Alitretinoin—Rash—Octreotide—thymus cancer	0.00162	0.00228	CcSEcCtD
Alitretinoin—Dermatitis—Octreotide—thymus cancer	0.00162	0.00227	CcSEcCtD
Alitretinoin—Headache—Octreotide—thymus cancer	0.00161	0.00226	CcSEcCtD
Alitretinoin—ABCB1—pituitary gland—thymus cancer	0.00154	0.00538	CbGeAlD
Alitretinoin—Nausea—Octreotide—thymus cancer	0.00153	0.00214	CcSEcCtD
Alitretinoin—ABCB1—lymphoid tissue—thymus cancer	0.00146	0.0051	CbGeAlD
Alitretinoin—ABCB1—bone marrow—thymus cancer	0.00133	0.00465	CbGeAlD
Alitretinoin—ABCB1—thyroid gland—thymus cancer	0.00133	0.00464	CbGeAlD
Alitretinoin—ABCB1—lung—thymus cancer	0.00121	0.00421	CbGeAlD
Alitretinoin—ABCB1—lymph node—thymus cancer	0.000825	0.00288	CbGeAlD
